Cardiovascular disease is the number one cause of death globally, accounting for 17.3 million deaths per year. In South Africa, about 210 people die from heart disease each day.
From Thursday until Sunday, the South African Heart Association is hosting the 18th Heart Congress.
The focus of this gathering will be on heart failure awareness, and the advances that have been made in this field, 50 years after the world's first heart transplant, which was performed in South Africa.
Stephen Grootes spoke to John McMurray, professor in Cardiology at the Institute of Cardiovascular and Medical Sciences.
He has conducted a paradigm study that assesses treatments and patients with heart failure.
For the first time in 15 years, we have demonstrated that this new treatment that we examined in the trial can reduce death and improve survival, also reduce submission to hospital and also prevent the progressive deterioration of quality of life...— John McMurray, Professor in Cardiology at the Institute of Cardiovascular and Medical Sciences
Essentially what the treatment does is, it sort of enhances the body's own attempts to correct the problem in heart failure and also blocks some of the bad things going on in the condition, so a dual action drug.— John McMurray, Professor in Cardiology at the Institute of Cardiovascular and Medical Sciences
Click on the link below to listen to the full audio...